NCT01375569View on ClinicalTrials.gov

TRC105 for Liver Cancer That Has Not Responded to Sorafenib

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 22, 2011

Primary Completion Date

February 1, 2014

Study Completion Date

December 1, 2015

Conditions
Hepatocellular CarcinomaHepatocellular CancerCarcinoma, Hepatocellular
Interventions
DRUG

TRC105

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01375569 - TRC105 for Liver Cancer That Has Not Responded to Sorafenib | Biotech Hunter | Biotech Hunter